| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | President And CEO
1 company
Jiang Wenbin serves as a President And CEO at CTKB. Across recent SEC filings that breaks down to 0 buys and 23 sells. Those positions are worth an estimated $26.0M at current prices.
Historically, Jiang Wenbin's trades have earned a strong insider score of 75/100 across 22 rated trades. Over a 12-month horizon, 90.9% of those trades were profitable, with an average 12-month return of +23.7%.
The biggest single holding is CTKB (~$26.0M) as President And CEO. The recent filings there lean toward selling, a net 440,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 7, 2022 | CTKB Cytek Biosciences, Inc. | President And CEO | Sale+OE | 20,000 | $12.65 | $253,052.00 | -0.3% | -12.5% | -18.6% | |
| Feb 7, 2022 | CTKB Cytek Biosciences, Inc. | President And CEO | Sell | 20,000 | $14.40 | $288,000.00 | -0.3% | -46.4% | -7.6% |